{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:25:42Z","timestamp":1760217942461},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Advancing a Healthier Wisconsin \u2013 Patient-Centered Outcomes Research Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To examine morphine milligram equivalent (MME) trends, use of concurrent opioids and benzodiazepines, and opioid-related emergency department (ED) visits or hospitalizations in a national cohort of patients on chronic opioid therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Retrospective cohort analysis of prospectively collected data from the Truven Health MarketScan Commercial Claims and Encounters database from 2009 to 2015. This includes individuals in both the Commercial Claims and Medicare Supplemental databases of MarketScan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>MME comparisons of 1) patients on chronic opioids with and without opioid-related ED visits or hospitalizations, 2) patients on concurrent opioids and benzodiazepines with and without opioid-related ED visits or hospitalizations, and 3) patients on chronic opioids compared with those on concurrent opioid and benzodiazepine using the Student t test.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>MME decreased from 194\u2009mg in 2009 to 119\u2009mg in 2015 among patients on chronic opioids. Patients on opioids and benzodiazepines had higher doses than those on opioids alone for all years (P\u2009&amp;lt;\u20090.001). Those with an opioid-related ED visit or hospitalization had a higher average MME than those without, for all years except 2009 (P\u2009&amp;lt;\u20090.05). Patients on chronic opioids or on concurrent benzodiazepine with an MME &amp;gt;50 had a twofold increased risk of having an opioid-related ED visit or hospitalization compared with those with an MME &amp;lt;50, for all years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although the average MME decreased over time, patients on combination opioid and benzodiazepine and those with opioid-related ED visits and hospitalizations had significantly higher doses.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pnz317","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T21:43:19Z","timestamp":1572558199000},"page":"1181-1187","source":"Crossref","is-referenced-by-count":4,"title":["Opioid Dose and Benzodiazepine Use Among Commercially Insured Individuals on Chronic Opioid Therapy"],"prefix":"10.1093","volume":"21","author":[{"given":"Cynthia","family":"Kay","sequence":"first","affiliation":[{"name":"Zablocki VA Medical Center, Milwaukee, Wisconsin"},{"name":"Medical College of Wisconsin, Milwaukee, Wisconsin"},{"name":"Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, Wisconsin, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Fergestrom","sequence":"first","affiliation":[{"name":"Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, Wisconsin, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Spanbauer","sequence":"first","affiliation":[{"name":"Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, Wisconsin, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L","family":"Jackson","sequence":"first","affiliation":[{"name":"Zablocki VA Medical Center, Milwaukee, Wisconsin"},{"name":"Medical College of Wisconsin, Milwaukee, Wisconsin"},{"name":"Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, Wisconsin, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"issue":"2","key":"2020061021344890600_pnz317-B1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: Commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am J Public Health"},{"key":"2020061021344890600_pnz317-B2","year":"2018"},{"key":"2020061021344890600_pnz317-B3","year":"2017"},{"issue":"2","key":"2020061021344890600_pnz317-B4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"key":"2020061021344890600_pnz317-B5","volume-title":"ACOEM Guidelines for Chronic Use of Opioids","year":"2008"},{"issue":"Suppl 3","key":"2020061021344890600_pnz317-B6","first-page":"S67","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2\u2013guidance","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"2020061021344890600_pnz317-B7"},{"issue":"13","key":"2020061021344890600_pnz317-B8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"2020061021344890600_pnz317-B9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1526-4637.2011.01260.x","article-title":"A history of being prescribed controlled substances and risk of drug overdose death","volume":"13","author":"Paulozzi","year":"2012","journal-title":"Pain Med"},{"issue":"11","key":"2020061021344890600_pnz317-B10","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/pme.12480","article-title":"Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients","volume":"15","author":"Zedler","year":"2014","journal-title":"Pain Med"},{"issue":"2","key":"2020061021344890600_pnz317-B11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: A cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med"},{"issue":"16","key":"2020061021344890600_pnz317-B12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinternmed.2010.273","article-title":"Emergency department visits among recipients of chronic opioid therapy","volume":"170","author":"Braden","year":"2010","journal-title":"Arch Intern Med"},{"key":"2020061021344890600_pnz317-B13","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: Retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"2020061021344890600_pnz317-B14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmedr.2017.12.010","article-title":"Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993\u20132014","volume":"9","author":"Hirschtritt","year":"2018","journal-title":"Prev Med Rep"},{"issue":"9","key":"2020061021344890600_pnz317-B15","doi-asserted-by":"crossref","first-page":"h2698.","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: Case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"2020061021344890600_pnz317-B16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2013.272","article-title":"Pharmaceutical overdose deaths, United States, 2010","volume":"309","author":"Jones","year":"2013","journal-title":"JAMA"},{"issue":"1\u20132","key":"2020061021344890600_pnz317-B17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2010.05.017","article-title":"Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP study","volume":"112","author":"Edlund","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2020061021344890600_pnz317-B18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2010.05.020","article-title":"Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: The TROUP study","volume":"150","author":"Sullivan","year":"2010","journal-title":"Pain"},{"key":"2020061021344890600_pnz317-B19","year":"2018"},{"key":"2020061021344890600_pnz317-B20","author":"Lazur","year":"2017"},{"key":"2020061021344890600_pnz317-B21","year":"2015"},{"issue":"15","key":"2020061021344890600_pnz317-B22","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"26","key":"2020061021344890600_pnz317-B23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: Changes in opioid prescribing in the United States, 2006-2015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2020061021344890600_pnz317-B24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jpain.2015.12.018","article-title":"Trends in opioid dosing among Washington state Medicaid patients before and after opioid dosing guideline implementation","volume":"17","author":"Sullivan","year":"2016","journal-title":"J Pain"},{"issue":"7","key":"2020061021344890600_pnz317-B25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Arch Intern Med"},{"issue":"9","key":"2020061021344890600_pnz317-B26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1503\/cmaj.100187","article-title":"Opioids for chronic noncancer pain: A new Canadian practice guideline","volume":"182","author":"Furlan","year":"2010","journal-title":"Can Med Assoc J"},{"key":"2020061021344890600_pnz317-B27","year":"2016"},{"key":"2020061021344890600_pnz317-B28","year":"2017"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/21\/6\/1181\/33376819\/pnz317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/21\/6\/1181\/33376819\/pnz317.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T01:53:34Z","timestamp":1591840414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/21\/6\/1181\/5658645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,12,5]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnz317","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2019,12,5]]}}}